Assignee profile:

Jubilant Generics Limited

City:

Noida

Country:

India

Published Applications:

13

Last publication date:

2022-11-24

Patent Grants:

8

Last grant date:

2022-10-18

Top Inventors for applications by Jubilant Generics Limited

These are the the leading inventors for applications assigned to Jubilant Generics Limited:

Recent patent applications by Jubilant Generics Limited

Jubilant Generics Limited based in Noida, IN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-11-24
US20220370477A1
Human necessities

Solid Oral Dosage Forms Of Dexamethasone

#2 | 2022-09-01
US20220273670A1
Human necessities

MODIFIED RELEASE SUSPENSION OF ESLICARBAZEPINE

#3 | 2022-08-25
US20220265552A1
Human necessities

ESLICARBAZEPINE SUSPENSION

#4 | 2021-12-02
US20210369619A1
Human necessities

TRANSMUCOSAL PHARMACEUTICAL COMPOSITIONS OF ANTIVIRAL DRUGS

#5 | 2021-11-25 ✅ Patent 11,471,543 granted on 2022-10-18
US20210361785A1
Human necessities

Pharmaceutical compositions of sulfur colloid and processes thereof

#6 | 2021-09-09 ✅ Patent 11,318,145 granted on 2022-05-03
US20210275539A1
Human necessities

Eslicarbazepine suspension

#7 | 2021-08-05
US20210236628A1
Human necessities

SELF-EMULSIFYING SOLID ORAL DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF

#8 | 2021-05-20 ✅ Patent 11,857,647 granted on 2024-01-02
US20210145987A1
Human necessities

Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof

#9 | 2020-08-13 ✅ Patent 10,918,630 granted on 2021-02-16
US20200253946A1
Human necessities

Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof

#10 | 2020-07-16 ✅ Patent 11,331,324 granted on 2022-05-17
US20200222421A1
Human necessities

Modified release suspension of eslicarbazepine

#11 | 2020-07-16 ✅ Patent 11,642,351 granted on 2023-05-09
US20200222420A1
Human necessities

Eslicarbazepine suspension

#12 | 2020-04-30 ✅ Patent 10,889,549 granted on 2021-01-12
US20200131137A1
Chemistry; metallurgy

Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof

#13 | 2017-11-02 ✅ Patent 9,932,336 granted on 2018-04-03
US20170313699A1
Chemistry; metallurgy

Process for the preparation of apixaban and intermediates thereof

Also check out Jubilant Generics Limited's (Noida, India) applicant profile with 7 patent applications submitted.

AssigneeID:

157615 ⎘